A pathological complete response in malignant pleural mesothelioma after combination chemotherapy with Carboplatin and pemetrexed.
作者信息
Kao Steven Chuan-Hao, McCaughan Brian, Muljono Anita, Boyer Michael
机构信息
Department of Medical Oncology, Sydney Cancer Centre, Sydney, Australia.
出版信息
J Thorac Oncol. 2010 Mar;5(3):405-6. doi: 10.1097/JTO.0b013e3181c8cb16.
PMID:20186029
Abstract
摘要
相似文献
1
A pathological complete response in malignant pleural mesothelioma after combination chemotherapy with Carboplatin and pemetrexed.
J Thorac Oncol. 2010 Mar;5(3):405-6. doi: 10.1097/JTO.0b013e3181c8cb16.
2
Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma.培美曲塞联合卡铂治疗恶性胸膜间皮瘤的II期研究。
J Clin Oncol. 2006 Mar 20;24(9):1443-8. doi: 10.1200/JCO.2005.04.3190.
3
Pemetrexed combination improves mesothelioma survival.
Lancet Oncol. 2005 Aug;6(8):548. doi: 10.1016/s1470-2045(05)70268-0.
4
Pemetrexed and cisplatin for malignant pleural mesothelioma: a new standard of care?培美曲塞和顺铂治疗恶性胸膜间皮瘤：一种新的治疗标准？
J Clin Oncol. 2003 Jul 15;21(14):2629-30. doi: 10.1200/JCO.2003.02.043.
5
Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaïve patients with malignant pleural mesothelioma: results of the International Expanded Access Program.培美曲塞联合顺铂或培美曲塞联合卡铂用于初治恶性胸膜间皮瘤患者：国际扩大可及项目的结果
J Thorac Oncol. 2008 Jul;3(7):756-63. doi: 10.1097/JTO.0b013e31817c73d6.
6
Carboplatin and pemetrexed in the management of malignant pleural mesothelioma: a realistic treatment option?卡铂和培美曲塞用于治疗恶性胸膜间皮瘤：一种切实可行的治疗选择？
Lung Cancer. 2009 May;64(2):207-10. doi: 10.1016/j.lungcan.2008.08.016. Epub 2008 Oct 15.
7
Pemetrexed-cisplatin combination in mesothelioma.培美曲塞-顺铂联合方案治疗间皮瘤
Expert Rev Anticancer Ther. 2005 Apr;5(2):231-7. doi: 10.1586/14737140.5.2.231.
8
Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM).培美曲塞联合卡铂治疗恶性胸膜间皮瘤（MPM）患者的II期研究。
Ann Oncol. 2008 Feb;19(2):370-3. doi: 10.1093/annonc/mdm501. Epub 2007 Dec 20.
9
[Prognosis related clinical and molecular factors in malignant pleural mesothelioma].恶性胸膜间皮瘤的预后相关临床和分子因素
Zhonghua Jie He He Hu Xi Za Zhi. 2013 Mar;36(3):162-8.
Zotero 插件